EFFECT OF TAMOXIFEN ON REGULATION OF VIRAL REPLICATION AND HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) LONG TERMINAL REPEAT-DIRECTED TRANSCRIPTION IN CELLS CHRONICALLY INFECTED WITH HIV-1

  • 1 February 1990
    • journal article
    • research article
    • Vol. 75  (3) , 696-703
Abstract
The protein kinase C (PKC) activator phorbol myristate acetate (PMA) was used to upregulate viral replication in a clone of promonocytic cells chronically infected with human immunodeficiency virus (HIV)-1. Induction of virus could be inhibited by the triphenylethylene anti-estrogen tamoxifen at concentrations that had minimal effects on cellular DNA synthetic responses and cell cycle kinetics. This effect correlated with tamoxifen''s ability to block PMA-mediated enhancement of HIV-promoter-driven trans-activation in cells of monocyte and CD4+ T-lymphocyte lineages. No interference with a primary infection was noted. Tamoxifen''s mechanism of action may relate both to its capacity to inhibit PKC and to consensus sequences for gonadal steroid responsive elements in the HIV long terminal repeat, as it was able to partially inhibit another HIV activator, 5-azacytidine, which does not modulate PKC function. The finding that replication of HIV in a model for low-level chronic or latent infection is amenable to a nonimmunosuppressive steroid antagonist may suggest approaches to pharmacologic intervention early in HIV infection.